An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms - PubMed (original) (raw)

An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms

M Dammerman et al. Proc Natl Acad Sci U S A. 1993.

Abstract

Five DNA polymorphisms were detected in the promoter of the apolipoprotein CIII gene of a type III hyperlipidemic subject with severe hypertriglyceridemia (HTG). The polymorphic sites were C-641-->A, G-630--> A, T-625-->deletion, C-482-->T, and T-455-->C, with the previously reported base at each site designated allele 1 and the variant base designated allele 2. The sites were in strong linkage disequilibrium with each other and with a polymorphic Sst I site in the apolipoprotein CIII 3' untranslated region whose presence (S2 allele) has previously been shown to be associated with HTG. The distribution of haplotypes of the form -625 -482 Sst I among 78 normolipidemic adults and 79 adults with severe HTG was estimated by maximum likelihood analysis. The 211 haplotype was estimated to be 3.8-fold more common in normal subjects than in HTG subjects (estimated proportions, 0.186 and 0.049, respectively). This haplotype was associated with reduced HTG risk (relative risk, 0.28; P = 0.005) when compared with other haplotypes lacking the Sst I site (S1 allele). The 222 haplotype was estimated to be present on 48 of the 54 S2-containing chromosomes observed and was associated with increased risk for HTG (relative risk, 3.14; P < 0.0025). These results support the existence of apolipoprotein CIII promoter/Sst I haplotypes conferring either protection against or susceptibility to severe HTG.

PubMed Disclaimer

Similar articles

• An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population.
  Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J. Zeng Q, et al. Hum Genet. 1995 Apr;95(4):371-5. doi: 10.1007/BF00208957. Hum Genet. 1995. PMID: 7705829
• Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia.
  Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E. Surguchov AP, et al. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):941-7. doi: 10.1161/01.atv.16.8.941. Arterioscler Thromb Vasc Biol. 1996. PMID: 8696957
• Hypertriglyceridemia and the apolipoprotein CIII gene locus: lack of association with the variant insulin response element in Italian school children.
  Shoulders CC, Grantham TT, North JD, Gaspardone A, Tomai F, de Fazio A, Versaci F, Gioffre PA, Cox NJ. Shoulders CC, et al. Hum Genet. 1996 Nov;98(5):557-66. doi: 10.1007/s004390050259. Hum Genet. 1996. PMID: 8882875
• Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein AI-CIII gene cluster on chromosome 11.
  Marasco O, Melina F, Mele E, Quaresima B, Zingone A, Focarelli E, Picciotti E, Martelli ML, Fotino L, Vigna MF, et al. Marasco O, et al. Hum Genet. 1993 Mar;91(2):169-74. doi: 10.1007/BF00222719. Hum Genet. 1993. PMID: 8096493
• Association of Sst I polymorphism in apolipoprotein C3 gene with hypertriglyceridaemia in coronary atherosclerotic heart disease and type II diabetes mellitus in Chinese population.
  Liu HK, Li XF, Zhang SZ, Ren Y, Yong-Xin, Liu YQ, Wang CT, Chen X, Hu YM, Zhang L. Liu HK, et al. Yi Chuan Xue Bao. 2005 Jan;32(1):11-8. Yi Chuan Xue Bao. 2005. PMID: 15715433

Cited by

• Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.
  Foulkes AS, Wohl DA, Frank I, Puleo E, Restine S, Wolfe ML, Dube MP, Tebas P, Reilly MP. Foulkes AS, et al. PLoS Med. 2006 Mar;3(3):e52. doi: 10.1371/journal.pmed.0030052. PLoS Med. 2006. PMID: 16417409 Free PMC article.
• Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.
  Shachter NS, Ebara T, Ramakrishnan R, Steiner G, Breslow JL, Ginsberg HN, Smith JD. Shachter NS, et al. J Clin Invest. 1996 Aug 1;98(3):846-55. doi: 10.1172/JCI118857. J Clin Invest. 1996. PMID: 8698877 Free PMC article.
• Association of the polymorphisms of the genes APOC3 (rs2854116), ESR2 (rs3020450), HFE (rs1799945), MMP1 (rs1799750) and PPARG (rs1801282) with lipodystrophy in people living with HIV on antiretroviral therapy: a systematic review.
  da Silva AS, Carvalho TL, do Ó KP, da Nóbrega DN, Dos Santos Souza R, da Silva Lima VF, Farias ICC, de Mendonça Belmont TF, de Mendonça Cavalcanti MDS, de Barros Miranda-Filho D. da Silva AS, et al. Mol Biol Rep. 2020 Jun;47(6):4779-4787. doi: 10.1007/s11033-020-05441-3. Epub 2020 Apr 22. Mol Biol Rep. 2020. PMID: 32323264
• Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events.
  Saki S, Saki N, Poustchi H, Malekzadeh R. Saki S, et al. Middle East J Dig Dis. 2020 Apr;12(2):65-88. doi: 10.34172/mejdd.2020.166. Middle East J Dig Dis. 2020. PMID: 32626560 Free PMC article. Review.
• Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.
  Dixit M, Choudhuri G, Saxena R, Mittal B. Dixit M, et al. Can J Gastroenterol. 2007 Sep;21(9):569-75. doi: 10.1155/2007/329342. Can J Gastroenterol. 2007. PMID: 17853951 Free PMC article.

References

1. 1. Lancet. 1983 Feb 26;1(8322):444-6 - PubMed
2. 1. J Clin Invest. 1992 Nov;90(5):1889-900 - PubMed
3. 1. Arteriosclerosis. 1984 Mar-Apr;4(2):97-102 - PubMed
4. 1. DNA. 1984 Dec;3(6):449-56 - PubMed
5. 1. J Clin Invest. 1985 Feb;75(2):384-90 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • NIAID Data Ecosystem - Find datasets on Infectious and Immune-mediated Diseases